Making sense of the estrogen paradox in pulmonary arterial hypertension

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 6, 2011, Pages 629-630

  De Jesus Perez, Vinicio A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

16ALPHA HYDROXYESTRONE; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CYTOCHROME P450 1B1; ENDOTHELIN 1; ENZYME VARIANT; ESTRADIOL; ESTROGEN RECEPTOR BETA; MONOCROTALINE; NICOTINAMIDE ADENINE DINUCLEOTIDE; SEMAXANIB;

ANGIOGENESIS; DEATH; EDITORIAL; ESTROGEN METABOLISM; FAMILIAL INCIDENCE; GENDER BIAS; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE HYPERTROPHY; HUMAN; HYPOXIA; IDIOPATHIC DISEASE; LUNG ARTERY PRESSURE; MUTATION; NONHUMAN; OVARIECTOMY; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURVIVAL RATE; UNSPECIFIED SIDE EFFECT;

ANIMALS; ESTROGENS; HYPERTENSION, PULMONARY; MALE;

EID: 80052930539     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201107-1184ED     Document Type: Editorial

References (15)

1. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009;53:1573-1619.
2. Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, et al. BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 2001;68:92-102. (Pubitemid 32048364)
3. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SK. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-223. (Pubitemid 17137857)
4. Badesch DB, Raskob GE, Elliott CG, Krichman AM, Farber HW, Frost AE, Barst RJ, Benza RL, Liou TG, Turner M, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010;137:376-387.
5. Austin ED, Cogan JD, West JD, Hedges LK, Hamid R, Dawson EP, Wheeler LA, Parl FF, Loyd JE, Phillips JA 3rd. Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females. Eur Respir J 2009;34:1093-1099.
6. Roberts KE, Fallon MB, Krowka MJ, Brown RS, Trotter JF, Peter I, Tighiouart H, Knowles JA, Rabinowitz D, Benza RL, et al. Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. Am J Respir Crit Care Med 2009;179:835-842.
7. Kiyatake K, Kakusaka I, Kasahara Y, Qi TM, Suzuki A, Nakano K, Kaneko N, Kitada M, Kuriyama T. Relationship between the converting ability of liver microsomes and monocrotaline-induced pulmonary hypertension in male, female and castrated male rats [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi 1994;32:125-129. (Pubitemid 24144411)
8. Farhat MY, Chen MF, Bhatti T, Iqbal A, Cathapermal S, Ramwell PW. Protection by oestradiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br J Pharmacol 1993;110:719-723. (Pubitemid 23279284)
9. Rabinovitch M, Gamble WJ, Miettinen OS, Reid L. Age and sex influence on pulmonary hypertension of chronic hypoxia and on recovery. Am J Physiol 1981;240:H62-H72.
10. Ahn BH, Park HK, Cho HG, Lee HA, Lee YM, Yang EK, Lee WJ. Estrogen and enalapril attenuate the development of right ventricular hypertrophy induced by monocrotaline in ovariectomized rats. J Korean Med Sci 2003;18:641-648. (Pubitemid 38030485)
11. Lahm T, Crisostomo PR, Markel TA, Wang M, Weil BR, Novotny NM, Meldrum DR. The effects of estrogen on pulmonary artery vasoreactivity and hypoxic pulmonary vasoconstriction: potential new clinical implications for an old hormone. Crit Care Med 2008;36:2174-2183.
12. Lahm T, Crisostomo PR, Markel TA, Wang M, Wang Y, Weil B, Meldrum DR. Exogenous estrogen rapidly attenuates pulmonary artery vasoreactivity and acute hypoxic pulmonary vasoconstriction. Shock 2008;30:660-667.
13. Umar S, Iorga A, Matori H, Nadadur RD, Li J, Maltese F, van der Laarse A, Eghbali M. Estrogen rescues preexisting severe pulmonary hypertension in rats. Am J Respir Crit Care Med 2011;184:715-723.
14. Jesmin S, Mowa CN, Sultana SN, Mia S, Islam R, Zaedi S, Sakuma I, Hattori Y, Hiroe M, Yamaguchi N. Estrogen receptor alpha and beta are both involved in the cerebral VEGF/Akt/NO pathway and cerebral angiogenesis in female mice. Biomed Res 2010;31:337-346.
15. Tofovic SP. Estrogens and development of pulmonary hypertension: interaction of estradiol metabolism and pulmonary vascular disease. J Cardiovasc Pharmacol 2010;56:696-708.